Dana Investment Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Dana Investment Advisors’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,063	Closed	-$345K	–	424
2022 Q3	$345K	Buy	+5,063	New	+$279K	0.02%	347

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Dana Investment Advisors's GBT Position: Q4 2022 in Review

Dana Investment Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 5,063 shares — an estimated $345K sold.

Dana Investment Advisors first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $345K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Dana Investment Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Dana Investment Advisors sold 5,063 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $345K.
Dana Investment Advisors first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Dana Investment Advisors's Global Blood Therapeutics, Inc. position peaked at $345K in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Dana Investment Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.